Klinger JR - Search Results

1

Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice.

Aliotta JM, Pereira M, Wen S, Dooner MS, Del Tatto M, Papa E, Goldberg LR, Baird GL, Ventetuolo CE, Quesenberry PJ, Klinger JR. Aliotta JM, et al. Among authors: klinger jr. Cardiovasc Res. 2016 Jun 1;110(3):319-30. doi: 10.1093/cvr/cvw054. Epub 2016 Mar 14. Cardiovasc Res. 2016. PMID: 26980205 Free PMC article.

2

Neutral endopeptidase inhibition attenuates development of hypoxic pulmonary hypertension in rats.

Klinger JR, Petit RD, Warburton RR, Wrenn DS, Arnal F, Hill NS. Klinger JR, et al. J Appl Physiol (1985). 1993 Oct;75(4):1615-23. doi: 10.1152/jappl.1993.75.4.1615. J Appl Physiol (1985). 1993. PMID: 8282611

3

Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.

Hill NS, Warburton RR, Pietras L, Klinger JR. Hill NS, et al. Among authors: klinger jr. J Appl Physiol (1985). 1997 Oct;83(4):1209-15. doi: 10.1152/jappl.1997.83.4.1209. J Appl Physiol (1985). 1997. PMID: 9338430 Free article.

4

Genetic disruption of atrial natriuretic peptide causes pulmonary hypertension in normoxic and hypoxic mice.

Klinger JR, Warburton RR, Pietras LA, Smithies O, Swift R, Hill NS. Klinger JR, et al. Am J Physiol. 1999 May;276(5):L868-74. doi: 10.1152/ajplung.1999.276.5.L868. Am J Physiol. 1999. PMID: 10330043

5

Stem cells and pulmonary metamorphosis: new concepts in repair and regeneration.

Aliotta JM, Passero M, Meharg J, Klinger J, Dooner MS, Pimentel J, Quesenberry PJ. Aliotta JM, et al. J Cell Physiol. 2005 Sep;204(3):725-41. doi: 10.1002/jcp.20318. J Cell Physiol. 2005. PMID: 15744751 Review.

6

Pulmonary arterial hypertension: an overview.

Klinger JR. Klinger JR. Semin Cardiothorac Vasc Anesth. 2007 Jun;11(2):96-103. doi: 10.1177/1089253207301447. Semin Cardiothorac Vasc Anesth. 2007. PMID: 17536113 Review.

7

Marrow cell infusion attenuates vascular remodeling in a murine model of monocrotaline-induced pulmonary hypertension.

Aliotta JM, Keaney PJ, Warburton RR, DelTatto M, Dooner MS, Passero MA, Quesenberry PJ, Klinger JR. Aliotta JM, et al. Among authors: klinger jr. Stem Cells Dev. 2009 Jun;18(5):773-82. doi: 10.1089/scd.2008.0237. Stem Cells Dev. 2009. PMID: 19072290 Free PMC article.

8

Tadalafil for the treatment of pulmonary arterial hypertension.

Klinger JR. Klinger JR. Expert Rev Respir Med. 2011 Jun;5(3):315-28. doi: 10.1586/ers.11.38. Expert Rev Respir Med. 2011. PMID: 21702653 Review.

9

C-type natriuretic peptide does not attenuate the development of pulmonary hypertension caused by hypoxia and VEGF receptor blockade.

Casserly B, Mazer JM, Vang A, Harrington EO, Klinger JR, Rounds S, Choudhary G. Casserly B, et al. Among authors: klinger jr. Life Sci. 2011 Sep 26;89(13-14):460-6. doi: 10.1016/j.lfs.2011.07.009. Epub 2011 Jul 27. Life Sci. 2011. PMID: 21820448 Free PMC article.

10

Combination therapy for the treatment of pulmonary arterial hypertension.

Levinson AT, Klinger JR. Levinson AT, et al. Among authors: klinger jr. Ther Adv Respir Dis. 2011 Dec;5(6):419-30. doi: 10.1177/1753465811411602. Epub 2011 Aug 17. Ther Adv Respir Dis. 2011. PMID: 21849335 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page